Immunohistochemical localization of chemokine CXCL14 in rat hypothalamic neurons

Neuroscience Letters

Volumn 487, Issue 3, 2011, Pages 335-340

  Yamamoto, Toshiharu ^a   Yamashita, Anzu ^a   Yamada, Kentaro ^a   Hata, Ryu Ichiro ^a  

^a KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

BRAK; Chemokine; CXCL14; Hypothalamus; Immunohistochemistry; Rat

Indexed keywords

BIOLOGICAL MARKER; CXCL14 CHEMOKINE; NEURON SPECIFIC NUCLEAR PROTEIN;

ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRAIN REGION; HYPOTHALAMUS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEDIAN EMINENCE; NONHUMAN; PARAVENTRICULAR THALAMIC NUCLEUS; PERIKARYON; PRIORITY JOURNAL; RAT;

ANIMALS; BLOTTING, WESTERN; CHEMOKINES, CXC; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; RATS; RATS, WISTAR;

EID: 78650519508     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.10.051     Document Type: Article

References (32)

1. Bajetto A., Bonavia R., Barbero S., Piccioli P., Costa A., Florio T., Schettini G. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J. Neurochem. 1999, 73:2348-2357.
2. Bajetto A., Bonavia R., Barbero S., Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 2002, 82:1311-1329.
3. Bakhiet M., Tjernlund A., Mousa A., Gad A., Strömblad S., Kuyiel W.A., Seiger A., Andersson J. RANTES promotes growth and survival of human first-trimester forebrain astrocytes. Nat. Cell Biol. 2001, 3:150-157.
4. Barbaria E.M., Kohl B., Buhren B.A., Hasenpusch-Thell K., Kruse F., Küry P., Martini R., Müller H.W. The α-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells. Neurobiol. Dis. 2009, 33:448-458.
5. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., Clercq E.D., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A. CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 2001, 4:702-710.
6. Dorf M.E., Berman M.A., Tanabe S., Heesen M., Luo Y. Atrocytes express functional chemokine receptors. J. Neuroimmunol. 2000, 111:109-121.
7. Frederick M.J., Henderson Y., Xu X., Deavers M.T., Sahin A.A., Wu H., Lewis D.E., El Naggar A.K., Clayman G.L. In vivo expression of the novel CXC chemokine BRAK in normal and carcerous human tissue. Am. J. Pathol. 2000, 156:1937-1950.
8. Gebicke-Haerter P.J., Speiss O., Ren L.Q., Li H., Dichmann S., Norgauer J., Boddeke H.W. Microglial chemokines and chemokine receptors. Prog. Brain Res. 2001, 132:525-532.
9. Giobannelli A., Limatola C., Ragozzini D., Mileo A.M., Ruggieri A., Ciotti M.T., Mercanti D., Santoni A., Eusebi F. CXC chemokines interleukin-8 (IL-8) and growth-related gene product α (GROα) modulate Purkinje neuron activity in mouse cerebellum. J. Neuroimmunol. 1998, 92:122-132.
10. Hromas R., Broxmeyer H.E., Kim C., Nakshatri H., Christopherson K., Azam M., Hou Y.H. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem. Biophys. Res. Commun. 1999, 255:703-706.
11. Kurth I., Willimann K., Schaerli P., Hunziker T., Clark-Lewis I., Moser B. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J. Exp. Med. 2001, 194:855-861.
12. Lazarini F., Casanove P., Tham T.N., de Clercq E., Arenzana-Seisdedos F., Baleux F., Bubois-Dalcq M. Differential signaling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes. Eur. J. Neurosci. 2000, 12:117-125.
13. Magni P., Dozio E., Ruscica M., Celotti F., Masini M.A., Prato P., Broccoli M., Mambro A., Morè M., Strollo F. Feeding behavior in mammals including humans. Ann. N. Y. Acad. Sci. 2009, 1163:221-232.
14. Mammalian Gene Collection (MGC) Program Team Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:16899-16903.
15. Meucci O., Fatatis A., Simen A.A., Bushell T.J., Gray P.W., Miller R.J. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14500-14505.
16. Meuter S., Moser B. Constitutive expression of CXCL14 in healthy human and murine epithelial tissues. Cytokine 2008, 44:248-255.
17. Nara N., Nakayama Y., Okamoto S., Tamura H., Kiyono M., Muraoka M., Tanaka K., Taya C., Shitara H., Ishii R., Yonekawa H., Minokoshi Y., Hara T. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J. Biol. Chem. 2007, 282:30794-30803.
18. Ozawa S., Kato Y., Ito S., Komori R., Shiiki N., Tsukinoki K., Ozono S., Maehata Y., Taguchi T., Imagawa-Ishiguro Y., Tsukuda M., Kubota E., Hata R.I. Restoration of BRAK/CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma. Cancer Sci. 2009, 100:2202-2209.
19. 2+ currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J. Neurochem. 2001, 78:960-971.
20. Rezaie P., Trillo-Pazos G., Everall I.P., Male D.K. Expression of β-chemokine receptors in human fetal astrocyte and microglial cocultures: potential role of chemokines in the developing CNS. Glia 2002, 37:64-75.
21. Robinson S., Tani M., Strieter R.M., Ransohoff R.M., Miller R.H. The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J. Neurosci. 1998, 18:10457-10463.
22. Schaerli P., Willimann K., Ebert L.M., Walz A., Moser B. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 2005, 23:331-342.
23. Schmid C.D., Melchior B., Masek K., Puntambekar S.S., Danielson P.E., Lo D.D., Sutcliffe J.G., Carson M.J. Differential gene expression in LPS/IFNγ activated microglia and macrophages: in vitro versus in vivo. J. Neurochem. 2009, 109(Suppl. 1):117-125.
24. Shellenberger T.D., Wang M., Gujrati M., Jayakumar A., Strieter R.M., Burdick M.D., Ioannides C.G., Efferson C.L., El-Naggar A.K., Roberts D., Clayman G.L., Frederick M.J. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res. 2004, 64:8262-82270.
25. Sleeman M.A., Fraser J.K., Murison J.G., Kelly S.L., Prestidge R.L., Palmer D.J., Watson J.D., Kumble K.D. B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR a-chemokine. J. Immunol. 2000, 12:677-689.
26. Starnes T., Rasila K.K., Robertson M.J., Brahmi Z., Dahl R., Christopherson K., Hromas R. The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy. Exp. Hematol. 2006, 34:1101-1105.
27. Tham T.N., Lazarini F., Franceschini I.A., Lachapelle F., Amara A., Dubois-Dalcq M. Developmental pattern of expression of the alpha chemokine stromal cell-derived factor 1 in the rat central nervous system. Eur. J. Neurosci. 2001, 13:845-856.
28. Vadasz C., Smiley J.F., Figarsky K., Saito M., Toth R., Gyetvai B.M., Oros M., Kovacs K.K., Mohan P., Wang R. Mesencephalic dopamine neuron number and tyrosine hydroxylase content: genetic control and candidate genes. Neuroscience 2007, 149:561-572.
29. Vandesande F., Dierickx K., De May J. The origin of the vasopressinergic and oxytocinergic fibers of the external region of the median eminence of the rat hypophysis. Cell Tiss. Res. 1977, 180:443-452.
30. N. Yajima, K. Izukuri, R. Hata, Production of conditional knockout mice for chemokine BMAC/CXCL14 gene by Cre/loxP system, Inflamm. Degeneration, in press.
31. Zlotnik A., Yoshie O., Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol. 2006, 7:243.
32. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.